Clinical Trial: Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605845) titled 'Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia' on April 29.

Brief Summary: The goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).

Study Start Date: April 14

Study Type: INTERVENTIONAL

Condition: Immune Thrombocytopenia

Intervention: DRUG: GL-2045

Administrative route: SC injection

Recruitment Status: RECRUITING

Sponsor: Gliknik Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....